Abstract
The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries
Highlights
In July last year, at the time the first issue of the Journal of Infection in Developing Countries was going to press, a group of infectious disease experts met in Siena, Italy, to consider the direction of another important new initiative in the fight against infectious diseases in developing countries: the Novartis Vaccines Institute for Global Health (NVGH)
The NVGH was created last year (2007) with the not-for-profit mission to develop effective and affordable vaccines for neglected infectious diseases in developing countries. It is a unique concept: an institute created by a large vaccine manufacturer to enable the knowledge and resources within the company to be used to make vaccines that are desperately needed in the developing world, but would not be profitable enough to attract the substantial investment required from commercial sources
The background and plans for NVGH were presented with talks by Nobel Prize Laureate, Prof
Summary
The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries Novartis Vaccines Institute for Global Health S.r.l., Via Fiorentina 1, 53100 The NVGH was created last year (2007) with the not-for-profit mission to develop effective and affordable vaccines for neglected infectious diseases in developing countries.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
